1843 Capital

About The Fund

1843 Capital is a venture capital firm that specializes in early-stage investments, focusing on Seed and Series A funding rounds. They target innovative startups and have a particular interest in the AgeTech and Longevity sectors, recognizing these areas as a massive and largely untapped opportunity. Their investment activities extend to various industries, including PropTech, AgroTech, FinTech and Financial Services, A.I. and Big Data, Web Security and Privacy, Analytics, Real Estate and Construction, and Mobility. They are driven by a mission to address the challenges and opportunities presented by the aging population, which they refer to as the 'Silver Tsunami.' With an extensive portfolio, they are strategic in their approach, emphasizing the importance of capital, counsel, and connectivity to support the growth of companies they invest in. 1843 Capital's team consists of seasoned professionals with over 100 years of combined investing, marketing, and operational experience, providing founders with substantial organizational support. The firm operates with a flexible investment range, preferring investments between $100,000 and $5,000,000, with a sweet spot of around $1,500,000 for its contributions. They show their social impact and commitment by helping to grow companies with the potential to significantly contribute to the 100+ year healthspan. 1843 Capital is also actively involved in the thought leadership and discussion surrounding the AgeTech market, indicating their dedication not just to investment but also to fostering community and innovation in these sectors. The firm values the significance of the over-65 demographic, which controls a large portion of disposable income in the United States and is set to comprise an even larger slice of the population by 2030. Their investments aim to align with the financial power and the growing needs of this age group, addressing a market poised to grow to $30 trillion by 2050. 1843 Capital operates with offices in Washington, DC, and New York, NY, aiming to serve as a significant player in the AgeTech and Longevity revolutions.